Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide Adjunctive vs Replacement in Partial Onset Seizures
NCT01630057Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of zonisamide in focal seizures (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Number of Participants with Adverse Events at 13 months. Started Sep 2009; status: completed.
02
Drugs
zonisamide
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT01630057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01630057.